PL359709A1 - Use of triazinetrione sulfones for combating coccidiosis - Google Patents

Use of triazinetrione sulfones for combating coccidiosis

Info

Publication number
PL359709A1
PL359709A1 PL01359709A PL35970901A PL359709A1 PL 359709 A1 PL359709 A1 PL 359709A1 PL 01359709 A PL01359709 A PL 01359709A PL 35970901 A PL35970901 A PL 35970901A PL 359709 A1 PL359709 A1 PL 359709A1
Authority
PL
Poland
Prior art keywords
triazinetrione
sulfones
combating coccidiosis
coccidiosis
combating
Prior art date
Application number
PL01359709A
Other languages
English (en)
Polish (pl)
Inventor
Gisela Greif
Iris Hepp
Hans-Christian Mundt
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of PL359709A1 publication Critical patent/PL359709A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/30—Only oxygen atoms
    • C07D251/34—Cyanuric or isocyanuric esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL01359709A 2000-08-17 2001-08-06 Use of triazinetrione sulfones for combating coccidiosis PL359709A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040174A DE10040174A1 (de) 2000-08-17 2000-08-17 Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
PCT/EP2001/009060 WO2002014288A1 (de) 2000-08-17 2001-08-06 Verwendung von triazintrion-sulfonen zur bekämpfung von coccidiosen

Publications (1)

Publication Number Publication Date
PL359709A1 true PL359709A1 (en) 2004-09-06

Family

ID=7652719

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01359709A PL359709A1 (en) 2000-08-17 2001-08-06 Use of triazinetrione sulfones for combating coccidiosis

Country Status (23)

Country Link
US (1) US7915257B2 (enExample)
EP (1) EP1311491A1 (enExample)
JP (1) JP2004506624A (enExample)
KR (1) KR100803078B1 (enExample)
CN (3) CN101361743A (enExample)
AR (1) AR030378A1 (enExample)
AU (2) AU2001278522B2 (enExample)
BR (1) BR0113268A (enExample)
CA (1) CA2419471C (enExample)
CZ (1) CZ300020B6 (enExample)
DE (1) DE10040174A1 (enExample)
HR (1) HRP20030194A2 (enExample)
HU (1) HUP0303701A3 (enExample)
MX (1) MXPA03001429A (enExample)
MY (1) MY136518A (enExample)
NO (1) NO20030585D0 (enExample)
NZ (1) NZ524200A (enExample)
PL (1) PL359709A1 (enExample)
SK (1) SK1652003A3 (enExample)
TW (1) TW200819431A (enExample)
WO (1) WO2002014288A1 (enExample)
YU (1) YU11703A (enExample)
ZA (1) ZA200301225B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
SI22751A (sl) 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740469A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740470A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
CN102973497A (zh) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 一种托曲珠利溶液及其制备方法
US11352332B2 (en) 2018-02-26 2022-06-07 AlzeCure Pharma AB Triazine derivatives for treating diseases relating to neurotrophins
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
JP7825401B2 (ja) * 2021-09-30 2026-03-06 株式会社ジーシーR&D 主材ペースト、及び歯科用アルギン酸塩印象材

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413722C3 (de) 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2414612A1 (de) 1974-03-26 1975-10-16 Bayer Ag 1-aryluracile, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2532363A1 (de) 1975-07-19 1977-02-03 Bayer Ag Substituierte 2-phenyl-1,2,4- triazin-3,5(2h,4h)-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4255231A (en) * 1979-06-13 1981-03-10 Congoleum Corporation Carpet etching
DE3314739A1 (de) * 1983-04-23 1984-10-25 Bayer Ag, 5090 Leverkusen 1-(4-(4-(fluoralkylmethylthio- oder -sulfinyl- oder -sulfonyl-)phenoxy) phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)-trione, verfahren zu ihrer herstellung und ihre verwendung als coccidiosemittel
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
US4808404A (en) * 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
HK1043019B (zh) 1998-10-08 2005-05-13 高新研究公司 用於预防和治疗原虫病的组合物和方法
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
HUP0104716A3 (en) * 1998-12-22 2003-10-28 Bayer Corp Pittsburgh Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them

Also Published As

Publication number Publication date
US7915257B2 (en) 2011-03-29
KR100803078B1 (ko) 2008-02-18
AU2001278522B9 (en) 2002-02-25
KR20030017659A (ko) 2003-03-03
NZ524200A (en) 2005-02-25
YU11703A (sh) 2006-01-16
US20040013699A1 (en) 2004-01-22
NO20030585L (no) 2003-02-06
DE10040174A1 (de) 2002-02-28
MY136518A (en) 2008-10-31
CZ300020B6 (cs) 2009-01-14
CN101361743A (zh) 2009-02-11
HUP0303701A3 (en) 2006-01-30
SK1652003A3 (en) 2004-02-03
AU2001278522B2 (en) 2007-03-22
EP1311491A1 (de) 2003-05-21
CA2419471A1 (en) 2003-02-14
ZA200301225B (en) 2004-02-16
HRP20030194A2 (en) 2005-10-31
CN1853635A (zh) 2006-11-01
BR0113268A (pt) 2003-07-08
NO20030585D0 (no) 2003-02-06
MXPA03001429A (es) 2004-05-04
CN1469868A (zh) 2004-01-21
CA2419471C (en) 2009-10-13
AU7852201A (en) 2002-02-25
WO2002014288A1 (de) 2002-02-21
TW200819431A (en) 2008-05-01
JP2004506624A (ja) 2004-03-04
HUP0303701A2 (hu) 2004-03-29
AR030378A1 (es) 2003-08-20

Similar Documents

Publication Publication Date Title
AU2002367262A8 (en) Personal user agent
AU3691301A (en) Treatment of fluorocarbon feedstocks
HUP0303701A3 (en) Use of triazinetrione sulfones for combating coccidiosis
AU2001278522A1 (en) Use of triazinetrione sulfones for combating coccidiosis
HUP0302478A3 (en) Pharmaceutical solutions of modafinil compounds
GB0011807D0 (en) Formulation for inhalation
GB2366727B (en) Antithixotropic cosmetic agent
PL368321A1 (en) Use of cystathionine
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
AU2874901A (en) Treatment of fluorocarbon feedstocks
AU3399401A (en) Treatment of fluorocarbon feedstocks
AU9409101A (en) Mesotrione formulations
IL155322A0 (en) Compositions comprising modafinil compounds
GB0009612D0 (en) Therapeutic formulations
GB2367489B (en) Use of antioxidants
PL363921A1 (en) Skin moisturizing composition
GB0030067D0 (en) Therapeutic agent
GB0009607D0 (en) Medical compositions
HUP0004670A2 (hu) Sebészeti eszközkészlet csigolyák rögzítésére
GB0129987D0 (en) Skin compositions
GB0024517D0 (en) Use of medicaments
GB0018466D0 (en) Keloid Treatment
AU6028101A (en) Medicament for combating respiratory depression
GB0021927D0 (en) Use of pharmaceutical combination
TW420029U (en) Improved structure of slide

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)